[HTML][HTML] Antidepressant withdrawal and rebound phenomena

J Henssler, A Heinz, L Brandt… - Deutsches Ärzteblatt …, 2019 - ncbi.nlm.nih.gov
Background Antidepressants are among the most commonly prescribed drugs worldwide.
They are often discontinued, frequently without the knowledge of the prescribing physician. It …

Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved

T Renoir - Frontiers in Pharmacology, 2013 - frontiersin.org
Besides demonstrated efficacy, selective serotonin reuptake inhibitors (SSRIs) hold other
advantages over earlier antidepressants such as greater tolerability and a wider range of …

Gray matter volume in major depressive disorder: a meta-analysis of voxel-based morphometry studies

CH Lai - Psychiatry Research: Neuroimaging, 2013 - Elsevier
We designed this study to perform a meta-analysis of gray matter (GM) findings in major
depressive disorder (MDD) by using the signed differential mapping (SDM) toolbox. The …

Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy

G Hasler, A Neumeister, JW van der Veen… - Biological …, 2005 - Elsevier
BACKGROUND: There is growing evidence that the brain gamma-aminobutyric acid (GABA)
system is involved in depression. Lowered plasma GABA levels were identified as a traitlike …

New insights on the antidepressant discontinuation syndrome

BH Harvey, FN Slabbert - … Psychopharmacology: Clinical and …, 2014 - Wiley Online Library
Objective Antidepressants are at best 50–55% effective. Non‐compliance and the
antidepressant discontinuation syndrome (ADS) are causally related yet poorly appreciated …

Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy

XJ Liu, YZ Zhou, ZF Li, J Cui, ZY Li… - Journal of Pharmacy …, 2012 - academic.oup.com
Objectives To investigate the antidepressant effects of Xiaoyaosan (XYS) in a chronic
unpredictable mild stress (CUMS) depression model. Methods The changes in behaviour …

Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression

BH Harvey, BS McEwen, DJ Stein - Biological Psychiatry, 2003 - Elsevier
Inappropriate discontinuation of drug treatment and noncompliance are a leading cause of
long-term morbidity during treatment of depression. Increasing evidence supports an …

Prospective studies of adverse events related to antidepressant discontinuation

M Fava - Journal of Clinical Psychiatry, 2006 - psychiatrist.com
The value of a prospective assessment of discontinuation-emergent symptoms proximal to
the termination of antidepressant treatment cannot be overstated. Though varying in …

β2‐Adrenoceptor agonist activity of higenamine

TJ Hudzik, M Patel, A Brown - Drug Testing and Analysis, 2021 - Wiley Online Library
Higenamine was included in the World Anti‐Doping Agency (WADA) Prohibited Substances
and Methods List as a β2‐adrenoceptor agonist in 2017, thereby resulting in its prohibition …

Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging

PE Sijens, JP Mostert, R Irwan, JH Potze… - Psychiatry Research …, 2008 - Elsevier
The antidepressant fluoxetine stimulates astrocytic glycogenolysis, which serves as an
energy source for axons. In multiple sclerosis patients fluoxetine administration may improve …